REGULATION OF AUTOPROTEOLYSIS OF THE HIV-1 AND HIV-2 PROTEASES WITH ENGINEERED AMINO-ACID SUBSTITUTIONS

被引:0
作者
ROSE, JR
SALTO, R
CRAIK, CS
机构
[1] UNIV CALIF SAN FRANCISCO, DEPT PHARMACEUT CHEM, SAN FRANCISCO, CA 94143 USA
[2] UNIV CALIF SAN FRANCISCO, DEPT PHARMACOL, SAN FRANCISCO, CA 94143 USA
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Autoproteolysis of the retroviral aspartyl proteases is a major obstacle to purification and analysis of these enzymes. A mutagenic approach to rendering autolytic cleavage sites less labile was applied to the primary. cleavage site between Leu5 and Trp6 in human immunodeficiency virus-1 (HIV-1) protease. From predictions based on known substrates it was concluded that amino acids Lys or Ser in place of Gln at position 7 would prevent cleavage at the Leu5-Trp6 peptide bond, therefore stabilizing the protein. Autoproteolytic stability was enhanced at least 100-fold by these mutations. At longer time points the protease was degraded at secondary sites which contained adequate substrate sequences but were conformationally restricted. Conversely, a mutation in HIV-2 protease which changed Lys7 to Gln rendered the protein 3-fold less stable and shifted the position of the initial autoproteolytic cleavage from Phe3-Ser4 to Leu5-Trp6. The effects of these mutations demonstrate that small changes in protein sequence can have a major impact on their autoproteolytic stability. The work described here suggests a general method for stabilizing proteases and perhaps other recombinantly produced proteins to autolysis.
引用
收藏
页码:11939 / 11945
页数:7
相关论文
共 27 条
  • [1] BABE LM, 1990, UCLA SYM BI, V110, P71
  • [2] BABE LM, 1991, STRUCTURE FUNCTION A, P543
  • [3] INCORPORATION OF A STABILIZING CA2+-BINDING LOOP INTO SUBTILISIN BPN'
    BRAXTON, S
    WELLS, JA
    [J]. BIOCHEMISTRY, 1992, 31 (34) : 7796 - 7801
  • [4] PURIFICATION AND BIOCHEMICAL-CHARACTERIZATION OF RECOMBINANT SIMIAN IMMUNODEFICIENCY VIRUS PROTEASE AND COMPARISON TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE
    GRANT, SK
    DECKMAN, IC
    MINNICH, MD
    CULP, J
    FRANKLIN, S
    DREYER, GB
    TOMASZEK, TA
    DEBOUCK, C
    MEEK, TD
    [J]. BIOCHEMISTRY, 1991, 30 (34) : 8424 - 8434
  • [5] REGULATION OF SERINE PROTEASE ACTIVITY BY AN ENGINEERED METAL SWITCH
    HIGAKI, JN
    HAYMORE, BL
    CHEN, S
    FLETTERICK, RJ
    CRAIK, CS
    [J]. BIOCHEMISTRY, 1990, 29 (37) : 8582 - 8586
  • [6] HUNKAPILLER MW, 1983, METHOD ENZYMOL, V91, P399
  • [7] HUMAN IMMUNODEFICIENCY VIRUS-1 PROTEASE .2. USE OF PH RATE STUDIES AND SOLVENT KINETIC ISOTOPE EFFECTS TO ELUCIDATE DETAILS OF CHEMICAL MECHANISM
    HYLAND, LJ
    TOMASZEK, TA
    MEEK, TD
    [J]. BIOCHEMISTRY, 1991, 30 (34) : 8454 - 8463
  • [8] MUTATING-P2 AND MUTATING-P1 RESIDUES AT CLEAVAGE JUNCTIONS IN THE HIV-1 POL POLYPROTEIN - EFFECTS ON HYDROLYSIS BY HIV-1 PROTEINASE
    JUPP, RA
    PHYLIP, LH
    MILLS, JS
    LEGRICE, SFJ
    KAY, J
    [J]. FEBS LETTERS, 1991, 283 (02) : 180 - 184
  • [9] KNOWLES JR, 1987, SCIENCE, V236, P1252